The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Trends in Upstream and Downstream Process Development for Antibody Manufacturing
Open accessAbstract
A steady increase of product titers and the corresponding change in impurity composition represent a challenge for development and optimization of antibody production processes. Additionally, increasing demands on product quality result in higher complexity of processes and analytics, thereby increasing the costs for product work-up. Concentration and composition of impurities are critical for efficient process development. These impurities can show significant variations, which primarily depend on culture conditions. They have a major impact on the work-up strategy and costs. The resulting “bottleneck” in downstream processing requires new optimization, technology and development approaches. These include the optimization and adaptation of existing unit operations respective to the new separation task, the assessment of alternative separation technologies and the search for new methods in process development. This review presents an overview of existing methods for process optimization and integration and indicates new approaches for future developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Best Practices for QSAR Model Development, Validation, and Exploitation
Tropsha, A. (2010) · Molecular Informatics · doi:10.1002/minf.201000061 · Cited by 2,024
Downstream processing of monoclonal antibodies—Application of platform approaches
Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S., & Low, D. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.026 · Cited by 876
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Optimal and consistent protein glycosylation in mammalian cell culture
Hossler, P., Khattak, S. F., & Li, Z. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp079 · Cited by 669
Industrialization of mAb production technology: The bioprocessing industry at a crossroads
Kelley, B. (2009) · mAbs · doi:10.4161/mabs.1.5.9448 · Cited by 667
Recent advances in large-scale production of monoclonal antibodies and related proteins
Shukla, A. A., & Thömmes, J. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.02.001 · Cited by 578
Recovery and purification process development for monoclonal antibody production
Liu, H. F., Ma, J., Winter, C., & Bayer, R. (2010) · mAbs · doi:10.4161/mabs.2.5.12645 · Cited by 561
Protein A chromatography for antibody purification
Hober, S., Nord, K., & Linhult, M. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.030 · Cited by 560
Membrane-based techniques for the separation and purification of proteins: An overview
Saxena, A., Tripathi, B. P., Kumar, M., & Shahi, V. K. (2009) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2008.07.004 · Cited by 546
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Extracellular vesicle-loaded hydrogels for tissue repair and regeneration
Ju, Y., Hu, Y., Yang, P., Xie, X., & Fang, B. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100522 · Cited by 440
Fisher, A. C., Kamga, M.-H., Agarabi, C., Brorson, K., Lee, S. L., & Yoon, S. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.08.008 · Cited by 180
Bioprocess Control: Current Progress and Future Perspectives
Rathore, A. S., Mishra, S., Nikita, S., & Priyanka, P. (2021) · Life · doi:10.3390/life11060557 · Cited by 141
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
Sandomenico, A., Sivaccumar, J. P., & Ruvo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176324 · Cited by 134
“Various cultivation parameters, such as media composition, pH, agitation, aeration, temperature, cell density, concentration of inducers, induction time and strategies affect the protein expression level depending upon expression system [82].”
BackgroundHa, T. K., Kim, D., Kim, C. L., Grav, L. M., & Lee, G. M. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107831 · Cited by 74
Kornecki, M., & Strube, J. (2018) · Bioengineering · doi:10.3390/bioengineering5010025 · Cited by 61
Self-citationEngineering Challenges in Therapeutic Protein Product and Process Design
Papathanasiou, M. M., & Kontoravdi, C. (2020) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2019.11.010 · Cited by 57
Konakovsky, V., Clemens, C., Müller, M., Bechmann, J., Berger, M., Schlatter, S., & Herwig, C. (2016) · Bioengineering · doi:10.3390/bioengineering3010005 · Cited by 44
In‐Line Monitoring of Protein Concentration With MIR Spectroscopy During UFDF
Milewska, A., Baekelandt, G., Boutaieb, S., Mozin, V., & Falconbridge, A. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202200050 · Cited by 18
Tran, T., Martinsson, E., Gustavsson, R., Tronarp, O., Nilsson, M., Hansson, K. R., Lundström, I., Mandenius, C.-F., & Aili, D. (2022) · Analytical Methods · doi:10.1039/d2ay01567f · Cited by 10
Nanoplasmonic Avidity‐Based Detection and Quantification of IgG Aggregates
Tran, T., Martinsson, E., Vargas, S., Lundström, I., Mandenius, C.-F., & Aili, D. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03446 · Cited by 8
In-line fiber optical sensor for detection of IgG aggregates in affinity chromatography
Tran, T., Gustavsson, R., Martinsson, E., Bergqvist, F., Axen, A., Lundström, I., Mandenius, C.-F., & Aili, D. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.465129 · Cited by 5
Continuous monitoring of IgG using immobilized fluorescent reporters
Goyal, A., Vu, B., Maranholkar, V., Patil, U., Kourentzi, K., & Willson, R. C. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28254 · Cited by 4
Metadata
- Authors
- Gronemeyer, P., Ditz, R., & Strube, J.
- Venue
- Bioengineering
- Publisher
- MDPI AG
- Published
- 2014-10-01
- Volume
- 1
- Issue
- 4
- Pages
- 188-212
- ISSN
- 2306-5354 (ISSN-L)
- OpenAlex
- W2100508150
- Cited by
- 329
- References
- 103
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.